This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (20)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in this journal  Topic Collections  • Neurogenetics  • Movement Disorders  • Genetic Counseling/ Testing/ Therapy  • Alert me on articles by topic  Social Bookmarking   What's this?

Shirley Rainier, PhD; Donald Thomas, BS; Debra Tokarz, BS; Lei Ming, MS, MD; Melanie Bui, BS; Erin Plein, BS; Xinping Zhao, PhD; Rosemary Lemons, BS; Roger Albin, MD; Colin Delaney, BS; David Alvarado, BS; John K. Fink, MD

Arch Neurol. 2004;61:1025-1029.

Background  Paroxysmal dystonic choreoathetosis (PDC) is characterized by attacks of involuntary movements that occur spontaneously while at rest and following caffeine or alcohol consumption. Previously, we and others identified a locus for autosomal dominant PDC on chromosome 2q33-2q35.

Objective  To identify the PDC gene.

Design  Analysis of PDC positional candidate genes by exon sequencing and reverse transcription–polymerase chain reaction.

Setting  Outpatient clinical and molecular genetic laboratory at a university hospital.

Patients  Affected (n = 12) and unaffected (n = 26) subjects from 2 unrelated families with PDC and 105 unrelated control subjects.

Results  We identified missense mutations in the myofibrillogenesis regulator gene (MR-1) in affected subjects in 2 unrelated PDC kindreds. These mutations were absent in control subjects and caused substitutions of valine for alanine at amino acid positions 7 and 9. The substitutions disturb interspecies conserved residues and are predicted to alter the MR-1 gene's amino-terminal helix. The MR-1 exon containing these mutations (exon 1) was expressed only in the brain, a finding that explains the brain-specific symptoms of subjects with these mutations.

Conclusions  Although MR-1 gene function is unknown, the precedence of ion channel disturbance in other episodic neurologic disorders suggests that the pathophysiologic features of PDC also involve abnormal ion localization. The discovery that MR-1 mutations underlie PDC provides opportunities to explore this condition's pathophysiologic characteristics and may provide insight into the causes of other paroxysmal neurologic disorders as well as the neurophysiologic mechanisms of alcohol and caffeine, which frequently precipitate PDC attacks.

From the Department of Neurology, University of Michigan, (Drs Rainier, Ming, Zhao, Albin, and Fink; Messrs Thomas, Delaney, and Alvarado; and Mss Tokarz, Bui, Plein, and Lemons) and the Geriatric Research, Education, and Clinical Center, Veterans Affairs Medical Center (Drs Fink and Albin), Ann Arbor.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTER

Significance of Recurrent Mutations in the Myofibrillogenesis Regulator 1 Gene
Ana Djarmati, Marina Svetel, Dragana Momcilovic, Vladimir Kostic, and Christine Klein
Arch Neurol. 2005;62(10):1641.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Genes for Movement
Roger N. Rosenberg
Arch Neurol. 2004;61(7):1006.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The monogenic primary dystonias
Muller
Brain 2009;0:awp172v1-awp172.
ABSTRACT | FULL TEXT  

Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence
Ghezzi et al.
Hum Mol Genet 2009;18:1058-1064.
ABSTRACT | FULL TEXT  

Genetics of infantile seizures with paroxysmal dyskinesia: the infantile convulsions and choreoathetosis (ICCA) and ICCA-related syndromes
Rochette et al.
J. Med. Genet. 2008;45:773-779.
ABSTRACT | FULL TEXT  

Review: Diagnosis and treatment of paroxysmal dyskinesias revisited
Unterberger and Trinka
Therapeutic Advances in Neurological Disorders 2008;1:67-74.
ABSTRACT  

Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1
Suls et al.
Brain 2008;0:awn113v2-awn113.
ABSTRACT | FULL TEXT  

Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia
Bruno et al.
Neurology 2007;68:1782-1789.
ABSTRACT | FULL TEXT  

Dystonia
Muller et al.
NEJM 2006;355:1935-1935.
FULL TEXT  

Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia
Spacey et al.
Neurology 2006;66:1588-1590.
ABSTRACT | FULL TEXT  

Significance of Recurrent Mutations in the Myofibrillogenesis Regulator 1 Gene
Djarmati et al.
Arch Neurol 2005;62:1641-1641.
FULL TEXT  

Presence of Alanine-to-Valine Substitutions in Myofibrillogenesis Regulator 1 in Paroxysmal Nonkinesigenic Dyskinesia: Confirmation in 2 Kindreds
Chen et al.
Arch Neurol 2005;62:597-600.
ABSTRACT | FULL TEXT  

The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway
Lee et al.
Hum Mol Genet 2004;13:3161-3170.
ABSTRACT | FULL TEXT  

Genes for Movement
Rosenberg
Arch Neurol 2004;61:1182-1182.
FULL TEXT  

Genes for Movement
Rosenberg
Arch Neurol 2004;61:1006-1006.
FULL TEXT